Search results

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better prognosis than those who receive add-on treatment late, or not all. Based on the results of a study from Lund University in Sweden, many new heart attacks, strokes and deaths could be prevented. Cardiovascular disease is by far the most common cause of death worldwide, and m

https://www.medicine.lu.se/article/simple-medication-can-save-lives-cardiac-patients - 2025-11-19

The Lund Stem Cell Center at Lund University welcomes the beginning of a new chapter with the appointment of its new leadership team. As of January 1, 2025, Professor Malin Parmar has assumed the role of Director, with Associate Professor Göran Karlsson stepping in as Deputy Director. Together, they bring decades of expertise, deep connections to the Lund research community, and a shared vision fo

https://www.medicine.lu.se/article/lund-stem-cell-center-welcomes-new-leadership-team - 2025-11-19

Researchers at Lund University have developed a new method to determine how the composition of proteins in blood changes in response to disease or organ damage. This could provide a deeper understanding of how diseases affect the body and be used to discover new biomarkers in the blood to aid in diagnosing complex medical conditions. Our organs consist of a variety of specific proteins that are vi

https://www.medicine.lu.se/article/protein-changes-reveal-diseases - 2025-11-19

Researchers at Lund University in Sweden have conducted a clinical study to show how a woman’s genetic profile provides information on which hormone treatment is most effective for in vitro fertilisation (IVF). The researchers have now developed a simple oral swab test that shows which hormone therapy is the best option for IVF treatment About 15 per cent of all couples of reproductive age are inv

https://www.medicine.lu.se/article/higher-success-rate-using-simple-oral-swab-test-ivf - 2025-11-19

Lund University in Sweden has been awarded an EU grant of 8.3 million euros for a new international doctoral programme in regenerative medicine and advanced therapy medicinal products. The aim is to improve the environment for regenerative medicine and ATMPs in Europe and facilitate cooperation between research and clinical application. It started as an idea at the Lund Stem Cell Center to train a

https://www.medicine.lu.se/article/83-million-euros-doctoral-programme-regenerative-medicine-and-atmp - 2025-11-19

Lund University Virus Centre (LUVC) holds festive inauguration (May 27). There was no ribbon-cutting ceremony, but instead a symbolic demolition of a 3D-printed giant virus marked the official opening of the virus centre.Three deans—current and former—as well as professors who have succeeded one another at the Faculty of Medicine and played key roles in bringing LUVC to life, attended the ceremony

https://www.medicine.lu.se/article/lund-universitys-virus-centre-inaugurated-symbolic-demolition-giant-virus - 2025-11-19

Blood clots can form in both arteries and veins. However, the reasons behind them differ, as do the consequences and the chances of preventing blood clots. In Sweden, almost half of all cases of venous thrombosis have a genetic explanation. A team of researchers from Lund University in Sweden has now discovered three gene variants that increase the risk of blood clots in the leg by up to 180 perce

https://www.medicine.lu.se/article/new-gene-variants-significantly-increase-risk-blood-clots - 2025-11-19

A Swedish multi-centre study led by researchers at Lund University shows a link between low fibre consumption and the presence of unstable or high-risk plaque in coronary arteries – the type of plaque that can trigger blood clots and cause heart attacks. The study also links dietary pattern to the composition of the plaques, i.e. how potentially dangerous they are. Using advanced cardiac imaging,

https://www.medicine.lu.se/article/link-identified-between-low-fibre-diet-and-more-dangerous-type-atherosclerotic-plaque-coronary2 - 2025-11-19

Professors Carl Borrebaeck, Thoas Fioretos, Lao Saal and Åke Borg share their experiences in transforming groundbreaking research into diagnostic tools, treatments, and biotech companies. From navigating commercialization strategies and securing long-term funding to building strong teams and mentoring future innovators, they reflect on what it truly takes to make science matter—outside the lab. Th

https://www.medicine.lu.se/article/how-turn-research-ideas-real-world-impact - 2025-11-19

Congratulations to Charlotte Ling who, together with Katarina Fagher and Alice Maguolo, has been awarded a grant of five million Danish kroner by the Novo Nordisk Foundation. The funding will support clinical research in precision medicine, focusing on epigenetic analysis of blood samples from 13,000 individuals. Epigenetic research paves the way for tailored type 2 diabetes treatmentCharlotte Lin

https://www.medicine.lu.se/article/charlotte-ling-receives-major-grant-clinical-diabetes-research - 2025-11-19

An experimental study from Lund University reveals for the first time that different Parkinson’s medications affect brain activity in distinct ways. This could explain why some patients develop impulsive and compulsive behaviors as a result of their treatment. The findings have been published in NPJ Parkinson’s Disease. Upon receiving treatment for their motor symptoms, many patients with Parkinso

https://www.medicine.lu.se/article/brain-activation-pattern-behind-impulsivity-parkinsons-treatment-discovered - 2025-11-19

In June, pediatric cancer experts from 16 countries gathered in Brussels for the annual meeting of the NOPHO-DB-SHIP consortium—an EU-wide collaboration working to improve outcomes for children with Acute Myeloid Leukemia (AML). In Sweden, the trial is coordinated by Lund University and Skåne University Hospital. At the center of this collaboration is the CHIP-AML22 trial—an international phase II

https://www.medicine.lu.se/article/brussels-meeting-advancing-personalised-treatment-childhood-aml-across-europe - 2025-11-19

A new study led by researchers at Lund University in Sweden, reveals that melanoma, the deadliest form of skin cancer, can in some cases be driven by mitochondrial processes, which can be effectively targeted using existing drugs. In preclinical laboratory experiments with melanoma cell cultures, researchers successfully eliminated cancer cells by using antibiotics and inhibitors of mitochondrial

https://www.medicine.lu.se/article/aggressive-skin-cancer-driven-mitochondrial-processes-existing-drugs-offer-promising-treatment-path - 2025-11-19

An international research team led from Lund University, has identified epigenetic biomarkers that can predict which people with type 2 diabetes are at risk of cardiovascular disease. The study is now published in Cell Reports Medicine. People with type 2 diabetes are up to four times more likely to have heart attacks, strokes, anginas and other coronary heart diseases than healthy people. Therefo

https://www.medicine.lu.se/article/biomarkers-reveal-risk-cardiovascular-disease-type-2-diabetes - 2025-11-19

In a new observational study, researchers at Lund University in Sweden looked at all children listed for heart transplants in the Nordic countries between 1986 and 2023. A total of 597 children were included in the study, 461 of whom received a transplant. The results show that survival rates have increased significantly over time despite the modest volumes in the region – a development that the r

https://www.medicine.lu.se/article/children-waiting-new-heart-study-shows-marked-improvement-survival-rates-and-importance-nordic - 2025-11-19

Type 2 diabetes is a chronic disease that usually requires lifelong treatment. A central goal for many diabetes researchers is to develop new cell therapies that can cure the disease. The Bo and Kerstin Hjelt Diabetes Foundation provides support to two diabetes researchers at Lund University Diabetes Centre who contribute with new knowledge to this research field. Type 1 diabetes is a condition wh

https://www.medicine.lu.se/article/hjelt-diabetes-foundation-supports-research-can-pave-way-new-cell-therapies - 2025-11-19

For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show that the repetitive part of the human genome plays an active role during early brain development and may also be relevant for understanding brain diseases. DNA carries the complete set of instructions an organism

https://www.medicine.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease-0 - 2025-11-19

An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialised immune cells. The discovery, published in Immunity, could pave the way for more precise and personalised cancer immunotherapies. The team has taken an important step toward harnessing the immune system to fight cancer. Their work describes how

https://www.medicine.lu.se/article/scientists-uncover-cellular-toolkit-reprogram-immune-cells-cancer-therapy - 2025-11-19

A simple urine test that can assess the risk of kidney cancer recurrence at an early stage could spare patients from frequent imaging scans, e.g. CT-scans, and thus reduce the associated radiation, anxiety and costs. This has been shown in a new international research study led by Lund University in Sweden. The results have now been published in European Urology Oncology. Globally, about 400,000 p

https://www.medicine.lu.se/article/urine-test-can-assess-risk-kidney-cancer-recurrence - 2025-11-19

A new international commission will pave the way for a global boost in maternal and newborn health. The project is led by a researcher at Lund University in Sweden, whose motivation stems from a formative experience witnessing a woman bleed to death unnecessarily during childbirth. “The time has come to put maternal and newborn health back at the heart of the global health agenda,” says Mehreen Za

https://www.medicine.lu.se/article/new-global-initiative-maternal-and-newborn-health-be-led - 2025-11-19